Home » Topics » Regulatory » Patents

Patents
RSS

Lundbeck reports PDE9 inhibitors

Dec. 28, 2015

Shanghai Fochon Pharmaceutical describes EGFR inhibitors

Dec. 28, 2015

Bayer Schering Pharma patents MMP-12 inhibitors

Dec. 28, 2015

Roche reports oxytocin agonists

Dec. 24, 2015

Merck & Co. develops sGC activators

Dec. 24, 2015

Esteve presents dual sigma1R/MOR-1 ligands

Dec. 24, 2015

Novartis describes nonsense mutation suppressors

Dec. 24, 2015

Astellas Pharma patents muscarinic M3 receptor PAMs

Dec. 24, 2015

Ketogen patents anticonvulsants

Dec. 23, 2015

Bristol-Myers Squibb discloses IDO inhibitors

Dec. 22, 2015

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...